Insilico talk: Predictive Biomanufacturing at the ELIXIR Innovation and SME Forum

11 October 2018

Insilico CEO Klaus Mauch will present a talk on Predicitve Biomanufacturing for the Factory of the Future as part of the ELIXIR Innovation and SME Forum "Data Driven Innovation in Industrial Biotechnology", organized by DECHEMA on 15-16 October 2018 | Frankfurt, Germany read more

Insilico is partner in a new joint research project to investigate neurodegenerative aspects of Alzheimer's disease

17 November 2017

The interdisciplinary consortium HiPSTAR tries to decipher the molecular mechanisms leading to Morbus Alzheimer. In particular, pathological alterations at the blood-brain-barrier are in the focus of this applied research project. The long-term goal of this collaborative effort is the development of new drugs and therapies targeting this predominant form of dementia. The project is coordinated by the University of Würzburg (Medical Faculty, Department of Tissue Engineering and Regenerative Medicine, TERM), and the Fraunhofer Institute for Molecular Biology and Applied Ecology, ScreeningPort, is a partner in the consortium. The German Ministry for Education and Research (Bundesministerium für Bildung und Forschung, BMBF) funds this project with an overall budget of 1.7 million Euro. read more

Future proofing with new software architecture: Insilico Biotechnology presents integrated software platform

05 April 2017

Insilico Biotechnology has combined its existing and future software applications for the development, analysis and control of biotechnological production processes into a single software platform, thus ensuring optimal integration into networked enterprise environments. read more

Insilico and GSK establish a collaboration to promote biomanufacturing of the future

01 March 2017

Insilico Biotechnology AG and GSK announce a strategic collaboration that will combine Insilico's leading technology for bioprocess simulation with GSK Vaccine's outstanding expertise and innovation in bioprocess development. read more